Future Cardiology
Published by Taylor & Francis
ISSN : 1479-6678 eISSN : 1744-8298
Abbreviation : Future Cardiol.
Aims & Scope
Research advances have contributed to improved outcomes across all specialities, but the rate of advancement in cardiology has been exceptional.
Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients' expectations of new drugs and devices.
Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy.
Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modelling and information management issues.
We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader.
Accessible 'at-a-glance' formats are important in an increasingly time-constrained clinical community.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 1 |
2024 | 1.60 |
Journal Rank
Year | Value |
---|---|
2024 | 12121 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 431 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.474 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 45 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
From Particles to Patients: Oxidative Stress and the Cardiovascular Effects of Air Pollution
Citation: 240
Authors: Mark R, Catherine A, Jeremy P
-
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ
Citation: 214
Authors: Lu, Wen-Jun, Stefanie, Fredric B, Salman
-
Kounis Syndrome: A New Twist On an Old Disease
Citation: 154
Authors: Nicholas G, Andreas, Grigorios, Sotiris, John
-
Rho Kinase As a Therapeutic Target in Cardiovascular Disease
Citation: 154
Authors: Michelle, Lei, Jianjian
-
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α
Citation: 149
Authors: Lu, Wen-Jun, Stefanie, Fredric B, Salman
-
Atrial Cardiopathy: A Broadened Concept of Left Atrial Thromboembolism Beyond Atrial Fibrillation
Citation: 141
Authors: Hooman, Peter M, WT, Mitchell SV, Elsayed Z
-
Astaxanthin, Oxidative stress, Inflammation and Cardiovascular Disease
Citation: 141
Authors: Robert G, Jeff S
-
Cardiotoxicity in Childhood Cancer Survivors: Strategies for Prevention and Management
Citation: 120
Authors: Danielle, Vivian I, Jacqueline M, Tracie L, Steven E